Wasserman Initiates Coverage on Pediatrix Medical Group (PDX) with a Buy

November 13, 2008 8:26 AM EST

Wasserman & Associates initiates coverage on Pediatrix Medical Group (NYSE: PDX) with a Buy.

Wasserman analyst says, "Even with a heavy acquisition agenda and a recession-induced lower birthrate, Pediatrix has been solidly profitable and growing this year, a trend expected to continue into 2009. Operating cash flow has been even more impressive, growing almost 15% for the first nine months of this year, allowing for two major share repurchase programs and the aforementioned acquisition ramp-up...We believe Pediatrix represents a fast-growing yet reasonably priced investment in the health care services area with an exemplary earnings track record, strong cash flow, leading market share position, and plenty of room for both internal and acquisition-related growth."

Pediatrix Medical Group, Inc. is a healthcare services company that focuses on physician services for newborn, maternal-fetal, pediatric subspecialty and anesthesia care.


Related Categories

New Coverage

Stocks Mentioned

PDX 31.70

+0.00 +0.00%
Volume: 571,098
Track PDX



Comments

Disagree
Jensen on Nov 24, 2008 12:56 PM

PDX's only growth is through acquisitions...they no longer have any cash to continue acquisitions and maybe not even enough to meet operating cash needs. In addition, because of the new line of credit they contractually are not allowed to give any dividends for the next five years. Doesn't sound like the kind of company I want to be putting money in with the given market. Why not get some income from your investments...say a 7% DIV yield availabe with a lot of strong companies that have the cash to weather the storm.


Add Your Comment